These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 9038078

  • 1. Current good manufacturing practice: proposed revision of certain requirements for finished pharmaceuticals; proposed rule, May 3, 1996 (61 FR 20103), [Docket No. 95N-0362]. Parenteral Drug Association.
    PDA J Pharm Sci Technol; 1996; 50(6):346-51. PubMed ID: 9038078
    [No Abstract] [Full Text] [Related]

  • 2. Regulatory and quality considerations for continuous manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium.
    Allison G, Cain YT, Cooney C, Garcia T, Bizjak TG, Holte O, Jagota N, Komas B, Korakianiti E, Kourti D, Madurawe R, Morefield E, Montgomery F, Nasr M, Randolph W, Robert JL, Rudd D, Zezza D.
    J Pharm Sci; 2015 Mar; 104(3):803-12. PubMed ID: 25830179
    [Abstract] [Full Text] [Related]

  • 3. Amendment to the current good manufacturing practice regulations for finished pharmaceuticals. Direct final rule.
    Food and Drug Administration, HHS.
    Fed Regist; 2007 Dec 04; 72(232):68064-70. PubMed ID: 18064770
    [Abstract] [Full Text] [Related]

  • 4. Quality control and good manufacturing practices: safety and efficacy of commercial herbals.
    Awang DV.
    Food Drug Law J; 1997 Dec 04; 52(3):341-4. PubMed ID: 10343036
    [No Abstract] [Full Text] [Related]

  • 5. PDA presentation at FDA Open Conference on Sterile Drug Manufacturing. Parenteral Drug Association.
    J Pharm Sci Technol; 1994 Dec 04; 48(1):4-6. PubMed ID: 8004417
    [No Abstract] [Full Text] [Related]

  • 6. Fake biotech drugs raise concerns.
    Fox JL.
    Nat Biotechnol; 2001 Jul 04; 19(7):603. PubMed ID: 11433258
    [No Abstract] [Full Text] [Related]

  • 7. FDA action on blood poisoning.
    Edwards CC, Bazell RJ.
    Science; 1971 Jul 30; 173(3995):379. PubMed ID: 5557318
    [No Abstract] [Full Text] [Related]

  • 8. The parenteral drug industry: recent findings.
    Fry EM.
    J Parenter Sci Technol; 1982 Jul 30; 36(2):55-8. PubMed ID: 7077464
    [No Abstract] [Full Text] [Related]

  • 9. Contaminated dietary supplements.
    Carvajal R.
    N Engl J Med; 2010 Jan 21; 362(3):274; author reply 274. PubMed ID: 20089984
    [No Abstract] [Full Text] [Related]

  • 10. Mutual recognition of pharmaceutical good manufacturing practice inspection reports, medical device quality system audit reports, and certain medical device product evaluation reports between the United States and the European Community--FDA. Final rule.
    Fed Regist; 1998 Nov 06; 63(215):60122-64. PubMed ID: 10187390
    [Abstract] [Full Text] [Related]

  • 11. Regulators scramble to tighten loopholes after heparin debacle.
    Jia H.
    Nat Biotechnol; 2008 May 06; 26(5):477-8. PubMed ID: 18464756
    [No Abstract] [Full Text] [Related]

  • 12. An FDA update on GMP's for aseptic processing.
    Fry EM.
    J Parenter Sci Technol; 1985 May 06; 39(4):154-7. PubMed ID: 3928863
    [No Abstract] [Full Text] [Related]

  • 13. Current approaches in leak testing pharmaceutical packages.
    Guazzo DM.
    PDA J Pharm Sci Technol; 1996 May 06; 50(6):378-85. PubMed ID: 9038084
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Current regulatory issues regarding parenteral inspections.
    Avallone H.
    J Parenter Sci Technol; 1989 May 06; 43(1):3-7. PubMed ID: 2926605
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Enforcement of the current good manufacturing practices for solid oral dosage forms after United States v. Barr Laboratories.
    Jimenez FA.
    Food Drug Law J; 1997 May 06; 52(1):67-82. PubMed ID: 10346711
    [No Abstract] [Full Text] [Related]

  • 18. A new coincidence model for single particle counters, Part II: Advances and applications.
    Knapp JZ, Lieberman A, Abramson LR.
    PDA J Pharm Sci Technol; 1994 May 06; 48(5):255-92. PubMed ID: 8000900
    [Abstract] [Full Text] [Related]

  • 19. Human and veterinary drugs: good manufacturing practices and proposed exemptions for certain OTC products.
    Fed Regist; 1978 Sep 29; 43(190 Pt 2):45013-89. PubMed ID: 10316700
    [No Abstract] [Full Text] [Related]

  • 20. Lessons learned from good manufacturing practice noncompliance.
    Peskoe MP.
    Food Drug Law J; 1995 Sep 29; 50(1):65-70. PubMed ID: 10342986
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.